Method for measurement of glycated hemoglobin by a rapid strip test procedure

• US 6,677,158 B2
• Filed: 03/14/2001
• Issued: 01/13/2004
• Est. Priority Date: 03/14/2001
• Status: Expired due to Fees

• Current Assignee: Exocell, Inc. (Glycadia, Inc.)
• Original Assignee: Exocell, Inc. (Glycadia, Inc.)
• Inventors: Wu, Van-Yu, Shearman, Clyde W., Hud, Elizabeth A.
• Primary Examiner(s): WALLENHORST, MAUREEN
• Application Number:
  US09/805,615
• Publication Number:
  US 20020164811A1
• Time in Patent Office: 1,035 Days
• Field of Search: 436/63, 436/66, 436/67, 436/164, 436/165, 436/166, 436/169, 436/170, 436/177, 436/178, 422/55, 422/56, 422/58, 422/60, 422/61, 422/101, 435/2
• US Class Current: 436/67
• CPC Class Codes: G01N 33/723 Glycosylated haemoglobin
• CPC Class Codes: Y10T 436/25375 Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
• CPC Class Codes: Y10T 436/255 including use of a solid sorbent, semipermeable membrane, or liquid extraction

Abstract

The present invention is directed to a novel method for measurement of glycated hemoglobin, as well as assay methods and processes that can be used outside the medical laboratory setting to determine the fraction of total hemoglobin that is glycated.

Claims

1. A method for determining glycated hemoglobin in a test sample, comprising the steps of:

a. applying a test sample of whole blood in which there are erythrocytes containing red-colored glycated and non-glycated hemoglobins to an application pad, wherein the application pad receives the test sample and is in fluid flow contact with a first capture site comprising a first porous material to retain substantially all of the glycated hemoglobin;

b. adding a solution to the application pad to disrupt erythrocytes in the applied sample, releasing hemoglobin from the erythrocytes and causing by fluid flow the released hemoglobin to disperse into the application pad and subsequently onto the first capture site;

c. permitting the first capture site to retain substantially all of the glycated hemoglobin;

d. flowing the test sample from the first capture site to a second capture site, the second capture site being in fluid flow contact with the first capture site, the second capture site comprising a second porous material that retains substantially all of the non-glycated hemoglobin;

e. permitting the second capture site to retain substantially all of the non-glycated hemoglobin;

f. flowing the test sample and residual solution from the second capture site to an end-piece wicking membrane, the end-piece wicking membrane being in fluid flow contact with the second capture site, the end-piece wicking membrane comprising a third porous material;

g. reading the intensity of the red color intrinsic to both glycated and non-glycated hemoglobin in the first and second capture sites with no requirement for additional colored tracer or reagent for readout; and

h. determining a ratio of the amount of glycated hemoglobin in the first capture site to the amount of non-glycated hemoglobin in the second capture site.

2. The method of claim 1 additionally comprising the step of selecting the first porous material to additionally comprise immobilized sugar binding molecules.

3. The method of claim 2 additionally comprising the step of selecting the sugar binding molecules to additionally comprise phenylboronic acid.

4. The method of claim 1 additionally comprising the step of selecting the second porous material to additionally comprise immobilized protein binding molecules.

5. The method of claim 4 additionally comprising the step of selecting the protein binding molecules to additionally comprise diethylaminoethyl.

6. The method of claim 1 additionally comprising the step of selecting the application pad to additionally comprise cellulose, rayon, cotton, cellulose acetate, glass fiber, nylon, nitrocellulose, cotton linter, or Polyvinylidene Fluoride.

7. The method of claim 6 additionally comprising the step of selecting the application pad to additionally comprise a synthetic polymer grade filter paper.

8. The method of claim 1 additionally comprising the step of selecting the first porous material to additionally comprise phenylboronate, lectins such as concanavalin A, broad bean lectin, Vicia sativa lectin, sweet pea lectin, Jack bean lectin, and lentil lectin, or glycation specific antibodies.

9. The method of claim 1 additionally comprising the step of selecting the second porous material to additionally comprise glass fiber, diethylaminoethyl, positively charged groups such as trinary alkylamines, quaternary alkylamines, quatemary alkyl alkanolamines, quaternary ammonium, polyamines and alkylamines;

negatively charged groups such as carboxylic acids and sulfonic acids;

hydrophobic groups such as aromatic, acrylic, hydroxyapatite, silica, alumina and alkyl; and

affinity reagents such as hemoglobin antibodies and wheat protease.

10. The method of claim 1 additionally comprising the step of selecting the third porous material to additionally comprise cotton linter.